[PDF][PDF] Biomarkers for Malignant Pleural Mesothelioma—A Novel View on Inflammation. Cancers 2021, 13, 658
M Vogl, A Rosenmayr, T Bohanes… - Malignant …, 2021 - researchgate.net
Malignant pleural mesothelioma (MPM) is an aggressive disease with limited treatment
response and devastating prognosis. Exposure to asbestos and chronic inflammation are …
response and devastating prognosis. Exposure to asbestos and chronic inflammation are …
Biomarkers for Malignant Pleural Mesothelioma—A Novel View on Inflammation. Cancers 2021, 13, 658
M Vogl, A Rosenmayr, T Bohanes, A Scheed… - 2021 - search.proquest.com
Malignant pleural mesothelioma (MPM) is an aggressive disease with limited treatment
response and devastating prognosis. Exposure to asbestos and chronic inflammation are …
response and devastating prognosis. Exposure to asbestos and chronic inflammation are …
[PDF][PDF] Biomarkers for Malignant Pleural Mesothelioma—A Novel View on Inflammation. Cancers 2021, 13, 658
M Vogl, A Rosenmayr, T Bohanes, A Scheed… - 2021 - academia.edu
Malignant pleural mesothelioma (MPM) is an aggressive disease with limited treatment
response and devastating prognosis. Exposure to asbestos and chronic inflammation are …
response and devastating prognosis. Exposure to asbestos and chronic inflammation are …